Skip to content 
Daiichi Sankyo Company, Limited manufactures and sells pharmaceutical products in Japan and internationally. The company offers Enhertu for the treatment of HER2 positive and low breast cancer, HER2 positive gastric or gastroesophageal junction adenocarcinoma, and HER2 positive solid tumors; Turalio, an oral small molecule for colony stimulating factor 1 receptor, KIT proto-oncogene receptor tyrosine kinase, and FMS-like tyrosine kinase 3, as well as symptomatic TGCT; Vanflyta, a FLT3 inhibitor for the treatment of acute myeloid leukemia; Injectafer, a ferric carboxymaltose injection for the treatment of iron deficiency; and Datroway for the treatment of HR positive and HER2 negative breast cancer, as well as NSCLC. It also provides Lixiana and Savaysa, which are direct factor Xa inhibitors; Minnebro, Olmetec, Olmetec Plus, Rezaltas, Sevikar, and Sevikar HCT, which are antihypertensive agents; Nilemdo that lowers cholesterol; Nustendi, a fixed-dose combination tablet of bempedoic acid and ezetimibe that reduces cholesterol; and Efient, an anti-platelet agent. In addition, the company offers Canalia for the treatment of type 2 diabetes mellitus; Emgality for the treatment of migraine attacks; Pralia for the treatment of osteoporosis and bone erosion associated with rheumatoid arthritis; Ranmark for the treatment of bone complications and GCTB; Tarlige for the treatment of neuropathic pain; Venofer for the treatment of iron deficiency anemia; Vimpat, an anti-seizure medication; and Reyvow for the treatment of acute migraine attacks. Further, it provides Daichirona, a coronavirus RNA vaccine; Flumist, an intranasal live attenuated influenza vaccine; adsorbed cell culture-derived influenza vaccine; measles rubella combined vaccine; and mump vaccine. The company was formerly known as Sankyo Co. Ltd. and changed its name to Daiichi Sankyo Company, Limited in September 2005. Daiichi Sankyo Company, Limited was founded in 1899 and is headquartered in Chuo, Japan. more
| Time Frame | DSNKY | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | 0.88% | 3.71% | -1.8% |
| 1-Month Return | -6.32% | 4.79% | -2.36% |
| 3-Month Return | -11.96% | 6.79% | 13.25% |
| 6-Month Return | -27.78% | -0.27% | 6.13% |
| 1-Year Return | -30.62% | 15.95% | 19.43% |
| 3-Year Return | -50.49% | 18.58% | 69.3% |
| 5-Year Return | -28.88% | 23.62% | 70.86% |
| 10-Year Return | 94.46% | 127.6% | 268.07% |
| Mar '22 | Mar '23 | Mar '24 | Mar '25 | Mar '26 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 1.04T | 1.28T | 1.60T | 1.89T | 2.25T | [{"date":"2022-03-31","value":46.42,"profit":true},{"date":"2023-03-31","value":56.79,"profit":true},{"date":"2024-03-31","value":71.15,"profit":true},{"date":"2025-03-31","value":83.79,"profit":true},{"date":"2026-03-31","value":100,"profit":true}] |
| Cost of Revenue | 353.33B | 363.52B | 415.32B | 415.80B | 709.39B | [{"date":"2022-03-31","value":49.81,"profit":true},{"date":"2023-03-31","value":51.24,"profit":true},{"date":"2024-03-31","value":58.55,"profit":true},{"date":"2025-03-31","value":58.61,"profit":true},{"date":"2026-03-31","value":100,"profit":true}] |
| Gross Profit | 691.56B | 914.95B | 1.19T | 1.47T | 1.54T | [{"date":"2022-03-31","value":44.86,"profit":true},{"date":"2023-03-31","value":59.35,"profit":true},{"date":"2024-03-31","value":76.95,"profit":true},{"date":"2025-03-31","value":95.38,"profit":true},{"date":"2026-03-31","value":100,"profit":true}] |
| Gross Margin | 66.19% | 71.57% | 74.07% | 77.96% | 68.49% | [{"date":"2022-03-31","value":84.9,"profit":true},{"date":"2023-03-31","value":91.8,"profit":true},{"date":"2024-03-31","value":95.01,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2026-03-31","value":87.85,"profit":true}] |
| Operating Expenses | 618.54B | 794.37B | 974.78B | 1.14T | 1.32T | [{"date":"2022-03-31","value":46.79,"profit":true},{"date":"2023-03-31","value":60.09,"profit":true},{"date":"2024-03-31","value":73.74,"profit":true},{"date":"2025-03-31","value":86.13,"profit":true},{"date":"2026-03-31","value":100,"profit":true}] |
| Operating Income | 73.03B | 120.58B | 211.59B | 331.93B | 219.81B | [{"date":"2022-03-31","value":22,"profit":true},{"date":"2023-03-31","value":36.33,"profit":true},{"date":"2024-03-31","value":63.75,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2026-03-31","value":66.22,"profit":true}] |
| Total Non-Operating Income/Expense | 851.00M | 12.57B | 51.11B | 45.95B | 92.33B | [{"date":"2022-03-31","value":0.92,"profit":true},{"date":"2023-03-31","value":13.61,"profit":true},{"date":"2024-03-31","value":55.35,"profit":true},{"date":"2025-03-31","value":49.77,"profit":true},{"date":"2026-03-31","value":100,"profit":true}] |
| Pre-Tax Income | 73.52B | 126.85B | 237.23B | 355.63B | 279.32B | [{"date":"2022-03-31","value":20.67,"profit":true},{"date":"2023-03-31","value":35.67,"profit":true},{"date":"2024-03-31","value":66.71,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2026-03-31","value":78.54,"profit":true}] |
| Income Taxes | 6.54B | 17.67B | 36.22B | 59.87B | 3.77B | [{"date":"2022-03-31","value":10.93,"profit":true},{"date":"2023-03-31","value":29.51,"profit":true},{"date":"2024-03-31","value":60.49,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2026-03-31","value":6.3,"profit":true}] |
| Income After Taxes | 66.97B | 109.19B | 201.02B | 295.76B | 275.55B | [{"date":"2022-03-31","value":22.64,"profit":true},{"date":"2023-03-31","value":36.92,"profit":true},{"date":"2024-03-31","value":67.97,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2026-03-31","value":93.17,"profit":true}] |
| Income From Continuous Operations | 66.97B | 109.19B | 201.02B | 295.76B | 259.87B | [{"date":"2022-03-31","value":22.64,"profit":true},{"date":"2023-03-31","value":36.92,"profit":true},{"date":"2024-03-31","value":67.97,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2026-03-31","value":87.87,"profit":true}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2026-03-31","value":"-","profit":true}] |
| Net Income | 66.97B | 109.19B | 200.73B | 295.76B | 275.55B | [{"date":"2022-03-31","value":22.64,"profit":true},{"date":"2023-03-31","value":36.92,"profit":true},{"date":"2024-03-31","value":67.87,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2026-03-31","value":93.17,"profit":true}] |
| EPS (Diluted) | 0.28 | 0.42 | 0.73 | 47.11 | 0.94 | [{"date":"2022-03-31","value":0.59,"profit":true},{"date":"2023-03-31","value":0.89,"profit":true},{"date":"2024-03-31","value":1.54,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2026-03-31","value":1.99,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
| DSNKY | |
|---|---|
| Cash Ratio | 0.51 |
| Current Ratio | 2.42 |
| Quick Ratio | 1.64 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| DSNKY | |
|---|---|
| ROA (LTM) | 3.84% |
| ROE (LTM) | 15.81% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| DSNKY | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.58 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.42 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| DSNKY | |
|---|---|
| Trailing PE | 18.13 |
| Forward PE | 18.98 |
| P/S (TTM) | 0.01 |
| P/B | 2.79 |
| Price/FCF | NM |
| EV/R | 2.08 |
| EV/Ebitda | 12.66 |
| PEG | 1.66 |
Daiichi Sankyo Co Ltd ADR (DSNKY) share price today is $15.85
Yes, Indians can buy shares of Daiichi Sankyo Co Ltd ADR (DSNKY) on Vested. To buy
Yes, you can purchase fractional shares of Daiichi Sankyo Co Ltd ADR (DSNKY) via the Vested app. You can start investing in Daiichi Sankyo Co Ltd ADR (DSNKY) with a minimum investment of $1.
You can invest in shares of Daiichi Sankyo Co Ltd ADR (DSNKY) via Vested in three simple steps:
The 52-week high price of Daiichi Sankyo Co Ltd ADR (DSNKY) is $26.91. The 52-week low price of Daiichi Sankyo Co Ltd ADR (DSNKY) is $14.98.
The price-to-earnings (P/E) ratio of Daiichi Sankyo Co Ltd ADR (DSNKY) is 18.1264
The price-to-book (P/B) ratio of Daiichi Sankyo Co Ltd ADR (DSNKY) is 2.79
The dividend yield of Daiichi Sankyo Co Ltd ADR (DSNKY) is 2.91%
The market capitalization of Daiichi Sankyo Co Ltd ADR (DSNKY) is $28.70B
The stock symbol (or ticker) of Daiichi Sankyo Co Ltd ADR is DSNKY
Consider the share price of Daiichi Sankyo Co Ltd ADR as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Daiichi Sankyo Co Ltd ADR has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Daiichi Sankyo Co Ltd ADR shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Daiichi Sankyo Co Ltd ADR stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Daiichi Sankyo Co Ltd ADR and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Daiichi Sankyo Co Ltd ADR stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
